Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$15.15 USD
-1.11 (-6.83%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $15.04 -0.11 (-0.73%) 4:56 PM ET
2-Buy of 5 2
A Value A Growth F Momentum A VGM
Assembly Biosciences (ASMB) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$35.50 | $36.00 | $35.00 | 118.33% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Assembly Biosciences comes to $35.50. The forecasts range from a low of $35.00 to a high of $36.00. The average price target represents an increase of 118.33% from the last closing price of $16.26.
Analyst Price Targets (2 )
Broker Rating
Assembly Biosciences currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 2.33 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, two are Strong Buy, representing 66.67% of all recommendations. A month ago, Strong Buy represented 33.33%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 2 | 2 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.67 | 1.67 | 2.33 | 2.33 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/20/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/2/2024 | Mizuho SecuritiesUSA | Salim Syed | Strong Buy | Strong Buy |
8/9/2024 | H.C. Wainwright & Co. | Ed Arce | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.67 |
ABR (Last week) | 1.67 |
# of Recs in ABR | 3 |
Average Target Price | $35.50 |
LT Growth Rate | NA |
Industry | Medical - Generic Drugs |
Industry Rank by ABR | 49 of 253 |
Current Quarter EPS Est: | -2.02 |
ASMB FAQs
Assembly Biosciences, Inc. (ASMB) currently has an average brokerage recommendation (ABR) of 1.67 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for Assembly Biosciences, Inc. (ASMB) is $35.50. The current on short-term price targets is based on 2 reports.
The forecasts for Assembly Biosciences, Inc. (ASMB) range from a low of $35 to a high of $36. The average price target represents a increase of $118.33 from the last closing price of $16.26.
The current UPSIDE for Assembly Biosciences, Inc. (ASMB) is 118.33%
Based on short-term price targets offered by two analysts, the average price target for Assembly Biosciences comes to $35.50. The forecasts range from a low of $35.00 to a high of $36.00. The average price target represents an increase of 118.33% from the last closing price of $16.26.